🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: NHS England · Read original ↗
Tens of thousands of people living with vitiligo affecting their face are to be offered the first approved medicine on the NHS to restore lost skin colour. The new cream, known as ruxolitinib, will be offered to nearly 100,000 people aged 12 and over who have a form of the condition where white patches typically […]
This content is sourced from NHS England and reproduced for clinical reference. ClinicalIQ does not alter source content.